Revance Therapeutics
RVNC
$3.32
Share price
-22.61%
Change (1 day)
-90.71%
Change (1 year)
Categories
Revance Therapeutics (RVNC) - Total assets
Total assets on the balance sheet as of December 2023 : $0.47 B
According to Revance Therapeutics's latest financial reports the company's total assets are $0.47 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Revance Therapeutics - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.47 B | -17.78% |
| 2022-12-31 | $0.58 B | 9.55% |
| 2021-12-31 | $0.53 B | -26.25% |
| 2020-12-31 | $0.72 B | 111.65% |
| 2019-12-31 | $0.34 B | 50.34% |
| 2018-12-31 | $0.22 B | -23.45% |
| 2017-12-31 | $0.29 B | 44.7% |
| 2016-12-31 | $0.20 B | -25.91% |
| 2015-12-31 | $0.27 B | 43.31% |
| 2014-12-31 | $0.19 B | 749.94% |
| 2013-12-31 | $22.64 M | 68.7% |
| 2012-12-31 | $13.42 M | -66.38% |
| 2011-12-31 | $39.92 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 35,842.01% | 🇺🇸 USA |
 Biogen BIIB | $26.56 B | 5,452.80% | 🇺🇸 USA |
 MediciNova MNOV | $66.27 M | -86.15% | 🇺🇸 USA |